This episode of the Pharmaron DMPK Insights Podcast Series features Robert MacNeill (Director of Bioanalysis at Pharmaron), Professor Michael Bartlett (University Professor and Associate Dean for Science Education, Research and Technology at the College of Pharmacy, University of Georgia, and Professor at the Department of Metabolism, Digestion and Reproduction at Imperial College), and Dr. Guilherme Guimaraes (drug metabolism and pharmacokinetics scientist at Biogen).
These three experts in the field discuss oligonucleotide LC-MS, exploring the exciting challenges in this vital field, the pivotal nature of assay sensitivity, and the range of analytical approaches and technologies currently in use or under development.
The trio also explores a range of other topics, including:
- The impact of recent liquid chromatographic and mass spectral innovations on bioanalysis of these drug modalities
- The role and importance of innovation, most notably in terms of the growing profile of high-resolution mass spectrometry and the move toward chromatographic miniaturization
Acknowledgments
Produced from materials originally authored by Pharmaron Beijing Co., Ltd.
About Pharmaron
Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 17,000 employees, and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.